Get it on Google Play

FDA approves Edwards SAPIEN M3 as first transseptal mitral valve system

December 23, 2025 9:00 AM EST Send to a Friend
The U.S. Food and Drug Administration approved Edwards Lifesciences' (NYSE: EW) SAPIEN M3 mitral valve replacement system, marking the first ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login